MRNA Moderna Stock: 5 Price Scenarios After 137% Rally - Monday Predicted Opening Price? 🚨
1 extracted signal · 0 resolved · 1 still active
StockInvest.usIndependent analyst profile- Source published
- 18 Sept 2026, 22:43 UTC
- Recorded by Tahlil Plus
- 18 Sept 2026, 22:45 UTC
AI-generated source summary
The video presents a mixed outlook for MRNA stock. Short-term signals are positive, indicating a potential buying opportunity. The stock is currently trading at $154.04, which is considered undervalued. Technical analysis shows an upward trend supported by moving averages, suggesting bullishness. However, there are some minor weaknesses identified in the technical picture. The stock has a suggested stop-loss at $149.43, indicating a potential downside risk. For the short term, a target of $341.11 is projected, implying a significant upside. The overall market trend is considered bullish, with a predicted trend also leaning bullish. The stock exhibits medium daily movements and a medium risk profile. Insider trading data shows a net sell-off, with a negative insider power of -16.527. The P/E ratio is -21.85, suggesting the company is currently experiencing losses. Support levels are identified at $145.13, and resistance at $154.27. A break below $145.13 could signal further downside, while holding this level might lead to a bounce. The long-term outlook suggests potential growth, but risks remain due to current financial performance and recent insider sell activity.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.